Since intracellular levels of JNK3 are associated with cognitive performance and serve as a biomarker of synaptic dysfunction, dysregulation of JNK3 activity is associated with several neurodegenerative diseases, such as stroke, Alzheimer’s disease, Parkinson’s disease, and epilepsy. This evidence concerns the gene MAPK10 and epilepsy.